You are here

Journal of Psoriasis and Psoriatic Arthritis®

Journal of Psoriasis and Psoriatic Arthritis®

Published in Association with National Psoriasis Foundation
Other Titles in:
Dermatology | Rheumatology

eISSN: 24755311 | ISSN: 24755303 | Current volume: 9 | Current issue: 4 Frequency: Quarterly
The Journal of Psoriasis and Psoriatic Arthritis (JPPA) is a peer-reviewed specialty journal of the National Psoriasis Foundation for its professional members and for dermatology and rheumatology specialists and community. The purpose of the journal is to provide the latest research and practical treatment information about psoriasis, psoriatic arthritis and related comorbidities and conditions in a concise and easy-to-read format. JPPA bases its policies on the guidelines set forth by the International Committee of Medical Journal Editors. Earn AMA PRA Category 1 Credit(s)™ for selected articles.

This journal is a member of the Committee on Publication Ethics (COPE).

Journal CME

Accreditation: The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation: The National Psoriasis Foundation designates each Journal CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Claim Credit

Journal articles that are designated for CME credit will provide learners with a link to the accreditation information at the end of the article just before the reference list.

Manuscript Review CME

The National Psoriasis Foundation provides AMA PRA Category 1 Credits™ for reviewing manuscripts. A reviewer must meet the requirements of the ACCME for manuscript review in order to be awarded credit.

Accreditation: The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation: The National Psoriasis Foundation designates each manuscript review for a maximum of 3.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Manuscript reviews are reported by the Journal Administrator to the National Psoriasis Foundation on an annual basis. The National Psoriasis Foundation then contacts reviewers related to accreditation information and CME credit. For questions related to Manuscript Review, please email medicalaffairs@psoriasis.org.

The Journal of Psoriasis and Psoriatic Arthritis (JPPA) is a quarterly, peer-reviewed, specialty journal published by the National Psoriasis Foundation (NPF). The journal disseminates the latest clinical, translational, and basic research and practical treatment information about psoriasis, psoriatic arthritis, as well as related comorbidities and conditions. The goal of the JPPA is to provide readers with knowledge that advances their expertise, a goal accomplished by publishing evidence-based research.

Article Types:
JPPA publishes original research, review articles, case studies, commentary, and brief reports on all aspects of psoriatic disease including basic research, evaluation and diagnosis, heredity, pharmacotherapy, and symptom management.

Diversity, Equity, and Inclusion:
Psoriatic disease doesn’t discriminate. NPF advocates for improved access to care and meaningful access to treatments for all. JPPA is passionate about supporting diversity, equity, and inclusion in wider society through our publishing activities, which include ensuring diversity (ethnic and gender) in our editorial board, peer reviewers, and author base.

Editor-in-Chief
Bruce Strober, MD, PhD Clinical Professor of Dermatology, Yale University, New Haven, CT; Central Connecticut Dermatology, Cromwell, CT, USA
Founding Editors
Alice B. Gottlieb, MD, PhD Icahn School of Medicine at Mount Sinai, New York, NY, USA
John Y. M. Koo, MD University of California-San Francisco Medical Center, San Francisco, CA, USA
Mark Lebwohl, MD Icahn School of Medicine at Mount Sinai, New York, NY, USA
Senior Editors
Andy Blauvelt, MD, MBA Oregon Medical Research Center, Portland, OR, USA
Jeffrey M. Cohen, M.D. Yale School of Medicine, USA
Mona Shahriari, MD, FAAD Yale University, New Haven, CT; Central CT Dermatology, Cromwell, CT, USA
Eingun James Song, MD, FAAD, Co-CMO American Academy of Dermatology, Rosemont, IL, USA
Associate Editors
Lakshi Aldredge, MSN, ANP-C VA Portland Health Care System, Portland, OR, USA
Herve Bachelez, MD, PhD Hôpital Saint-Louis Sorbonne Paris Cité, Université Paris Diderot, Paris, France
Jerry Bagel, MD Psoriasis Treatment Center of Central New Jersey, East Windsor, NJ, USA
Luca Bianchi, MD University of Rome Tor Vergata, Rome, Italy
David R. Bickers, MD Columbia University Medical Center, New York, NY, USA
Robert Bissonnette, MD University of Montreal Hospital Centre, Montreal, Canada
Erin Boh, MD, PhD Tulane University School of Medicine, New Orleans, LA, USA
Anne M. Bowcock, PhD Icahn School of Medicine at Mount Sinai, New York, NY, USA
Jeffrey P. Callen, MD University of Louisville, Louisville, KY, USA
Vinod Chandran, MBBS, MD, DM, PhD University of Toronto, Department of Medicine, Division of Rheumatology, Toronto Western Hospital, Toronto, ON, Canada
Robin Christensen, BSc, MSc, PhD The Parker Institute, Copenhagen, Denmark
Kelly Cordoro, MD University of California, San Francisco, CA, USA
Jeffrey Crowley, MD Bakersfield Dermatology, Bakersfield, CA, USA
Kristina Callis Duffin, MD The University of Utah, Salt Lake City, UT, USA
Lawrence Eichenfield, MD University of California, San Diego, CA, USA
Charles N. Ellis, MD University of Michigan Medical School, Ann Arbor, MI, USA
Steven Feldman, MD, PhD Wake Forest Baptist Medical Center, Winston-Salem, NC, USA
Hassan Galadari, MD College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
Joel Gelfand, MD, MSCE University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
Dafna D. Gladman, MD University of Toronto; Krembil Research Institute; Centre for Prognosis Studies in Rheumatic Diseases, University Health Network, Toronto Western Hospital, Toronto, Canada
Kenneth Gordon, MD Medical College of Wisconsin, Milwaukee, WI, USA
Chris Griffiths, MB, MD University of Manchester, Manchester, UK
Percio Gulko, MD Icahn School of Medicine at Mount Sinai, New York, NY, USA
Philip Helliwell, MD University of Leeds, Leeds, UK
Sylvia Hsu, MD Baylor College of Medicine Houston, Houston, TX, USA
Abby Jacobson, MS, PA-C Delaware Valley Dermatology Group, LLC, Wilmington, DE, USA
Joseph L. Jorizzo, MD Wake Forest University School of Medicine, Winston-Salem, NC, USA; Weill Cornell Medical College, New York, NY, USA
Arthur Kavanaugh, MD University of California, San Diego, CA, USA
Neil Korman, MD, PhD University Hospitals Cleveland Medical Center, Cleveland, OH, USA
Gerald G. Krueger, MD University of Utah School of Medicine, Salt Lake City, UT, USA
Richard Langley, MD Dalhousie University, Halifax, NS, Canada
Thomas McCormick, PhD Case Western Reserve University, Cleveland, OH, USA
Philip Mease, MD University of Washington, Seattle, WA, USA
Nehal N. Mehta, MD, MSCE National Heart, Lung and Blood Institute, Bethesda, MD, USA
Luigi Naldi, MD Hospital San Bortolo, Vicenza, Italy
Amy Paller, MD Northwestern University, Chicago, IL, USA
Kim Papp, MD, PhD Probity Medical Research, Inc., Ontario, Canada
Lourdes M. Perez-Chada, MD, MMSc International Dermatology Outcome Measures (IDEOM) Research Fellow; Psoriasis and Psoriatic Arthritis Clinical Research Fellow; Brigham and Women's Hospital-Harvard Medical School, Boston, MA, USA
Jörg Prinz, MD Ludwig Maximilian University, Munich, Germany
Ronald Prussick, MD George Washington University, Washington D.C., USA
Lluís Puig, MD, PhD Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
Abrar Qureshi, MD, MPH Brown University, Providence, RI, USA
Kristian Reich, MD, PhD Dermatologikum Hamburg, Hamburg, Germany
Cheryl Rosen, MD, FRCPC University of Toronto, Toronto, Canada
David Rosmarin, MD Tufts Medical Center, Boston, MA, USA
Eric Ruderman, MD Northwestern Feinberg School of Medicine, Chicago, IL, USA
Caitriona Ryan, MD, FAAD St. Vincent's University Hospital, Blackrock Clinic, Dublin, Ireland
Enrique Soriano, MD, MS Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Mona Ståhle, MD, PhD Karolinska Institutet, Stockholm, Sweden
Stephen Stone, MD, FAAD SIU Medicine, Springfield, IL, USA
Paul Tebbey, PhD, MBA AbbVie, Chicago, IL, USA
Abby Van Voorhees, MD Eastern Virginia Medical School, Norfolk, VA, USA
John E. Wolf Jr., MA, MD Baylor College of Medicine, Houston, TX, USA
Jashin J. Wu, MD Dermatology Research and Education Foundation, Irvine, CA, USA
Melodie Young, MSN, ANP-C Modern Dermatology and Modern Research Associates, Dallas, TX, USA
  • ProQuest
  • PubMed Central (PMC)
  • Scopus
  • Manuscript submission guidelines can be accessed on Sage Journals.

    Individual Subscription, E-access


    Individual Subscription, Print Only


    Individual Subscription, Combined (Print & E-access)


    Institutional Subscription, E-access


    Institutional Backfile Purchase, E-access (Content through 1998)


    Institutional Subscription & Backfile Lease, E-access Plus Backfile (All Online Content)


    Institutional Subscription, Print Only


    Institutional Subscription, Combined (Print & E-access)


    Institutional Subscription & Backfile Lease, Combined Plus Backfile (Current Volume Print & All Online Content)


    Individual, Single Print Issue


    Institutional, Single Print Issue